Your browser doesn't support javascript.
loading
Findings from a discontinued clinical trial of favipiravir in high-risk patients with early-onset COVID-19.
Iwata, Satoshi; Kobayashi, Osamu; Kurashima, Kazuyoshi; Doi, Yohei; Kunishima, Hiroyuki; Shinkai, Masaharu; Tsushima, Kenji; Yamato, Masaya; Kano, Akira; Hibino, Makoto; Yamatake, Takahiro; Sakurai, Tsutomu; Ogura, Takashi.
Afiliación
  • Iwata S; Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan; Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Kobayashi O; Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan.
  • Kurashima K; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
  • Doi Y; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
  • Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Shinkai M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo, Japan.
  • Tsushima K; Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, Chiba, Japan.
  • Yamato M; Division of General Internal Medicine and Infectious Diseases, Rinku General Medical Center, Osaka, Japan.
  • Kano A; Fujimino Emergency Hospital, Saitama, Japan.
  • Hibino M; Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Kanagawa, Japan.
  • Yamatake T; Development Division, FUJIFILM Toyama Chemical Co., Ltd., Tokyo, Japan.
  • Sakurai T; Development Division, FUJIFILM Toyama Chemical Co., Ltd., Tokyo, Japan. Electronic address: tsutomu.sakurai@fujifilm.com.
  • Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
J Infect Chemother ; 30(3): 219-227, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37832822

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Amidas / COVID-19 Límite: Humans Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Amidas / COVID-19 Límite: Humans Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Japón